First Year of Commercialization, Alphamab Oncology Reports Full Year 2021 Financial Results and Business Highlights ...Middle East

SUZHOU, China, March 29, 2022 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) reported financial results for the full year ended December 31, 2021 and highlighted recent progress and upcoming milestones. Highlights First product launch: In November 2021, KN035 (Envafolimab) has...

Hence then, the article about first year of commercialization alphamab oncology reports full year 2021 financial results and business highlights was published today ( Wednesday 30/03/2022 - 06:01 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( First Year of Commercialization, Alphamab Oncology Reports Full Year 2021 Financial Results and Business Highlights )

Also on site :

• Road over canal in Penkridge closed as bridge reportedly collapses
• Saudi Arabia to unify LPG gas cylinder prices nationwide from January 2026
• 2 found dead after family disturbance reported in Concord